Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (16/10/2023) announced the following initial list of price concessions for October 2023:
Amisulpride 100mg tablets
Atorvastatin 10mg tablets
Atorvastatin 20mg tablets
Atorvastatin 40mg tablets
Carbocisteine 250mg/5ml oral solution
Chloramphenicol 1% eye ointment
Cinacalcet 30mg tablets
Co-amoxiclav 500mg/125mg tablets
Doxycycline 100mg capsules
Eplerenone 25mg tablets
Eplerenone 50mg tablets
Etoricoxib 60mg tablets
Flecainide 100mg tablets
Isotretinoin 20mg capsules
Levetiracetam 100mg/ml oral solution sugar free
Metoprolol 50mg tablets
Mometasone 0.1% ointment
Oxycodone 5mg/5ml oral solution sugar free
Pantoprazole 20mg gastro-resistant tablets
Quinine sulfate 200mg tablets
Rasagiline 1mg tablets
Risperidone 1mg/ml oral solution sugar free
Risperidone 500microgram tablets
Ropinirole 250microgram tablets
Rosuvastatin 10mg tablets
Rosuvastatin 20mg tablets
Rosuvastatin 40mg tablets
Topiramate 100mg tablets
Warfarin 1mg tablets
Zolmitriptan 2.5mg orodispersible tablets sugar free
For the full list of price concessions granted so far for October 2023, please visit our webpage: cpe.org.uk/priceconcessions
No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.
We encourage pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC. We are still working with the DHSC to agree concessionary prices for other drugs reported to be unavailable at the stated October Drug Tariff price. Please note that we cannot provide details of any generic products awaiting price concession approval from DHSC.
Please subscribe to our mailing list to receive email updates of any price concessions.
Further information on price concessions and FAQs about the process involved can be found on our website (cpe.org.uk/priceconcessions) To hear more on how the current price concessions system operates, pharmacy teams can now access a recording of our recent Medicines Supply and Concessions Briefing webinar here.
Improvements to the price concession system
Following significant concerns raised by pharmacies about the unsustainable level of prices imposed by DHSC in second half of 2022, it was agreed that an urgent review of the price concession setting system would take place.
Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system.
One of the solutions agreed between us and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.
Furthermore, from May 2023, DHSC has implemented a process to roll over prices to the following month for any concessions requested after the 23rd of the month provided these prices were agreed with us. We are also continuing to work with DHSC on how a ‘retrospective increased payment’ may apply, where appropriate. Further information regarding this concession ‘top-up’ mechanism will be issued once details are finalised.